AKBA - Akebia Therapeutics Inc Revenue Breakdown

Peers: KNSA BHC PRGO ALKS AMRX INDV LNTH TEVA VTRS TLX

| Held by: VTI IWM VXF IWN FESM VTWO SCHA VHT IWC SMLF

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.08	Insider Own	2.71%	Shs Outstand	267.90M	Perf Week	1.87%
Market Cap	292.40M	Forward P/E	-	EPS next Y	-0.23	Insider Trans	-7.37%	Shs Float	260.99M	Perf Month	5.83%
Enterprise Value	345.97M	PEG	-	EPS next Q	-0.04	Inst Own	39.51%	Short Float	11.19%	Perf Quarter	-21.58%
Income	-20.51M	P/S	1.26	EPS this Y	-620.00%	Inst Trans	-6.84%	Short Ratio	6.67	Perf Half Y	-33.94%
Sales	232.40M	P/B	10.67	EPS next Y	-62.50%	ROA	-6.10%	Short Interest	29.20M	Perf YTD	-32.30%
Book/sh	0.10	P/C	1.78	EPS next 5Y	-	ROE	-78.96%	52W High	4.08 -73.28%	Perf Year	-70.86%
Cash/sh	0.61	P/FCF	4.87	EPS past 3/5Y	65.70% 62.40%	ROIC	-11.06%	52W Low	0.82 32.49%	Perf 3Y	19.77%
Dividend Est.	-	EV/EBITDA	52.66	Sales past 3/5Y	-6.88% -4.37%	Gross Margin	80.46%	Volatility	6.31% 7.13%	Perf 5Y	-74.05%
Dividend TTM	-	EV/Sales	1.49	EPS Y/Y TTM	64.06%	Oper. Margin	2.28%	ATR (14)	0.07	Perf 10Y	-85.41%
Dividend Ex-Date	-	Quick Ratio	1.33	Sales Y/Y TTM	25.69%	Profit Margin	-8.83%	RSI (14)	55.01	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.40	EPS Q/Q	-233.99%	SMA20	10.12%	Beta	0.25	Target Price	4.20
Payout	-	Debt/Eq	7.96	Sales Q/Q	-6.61%	SMA50	-4.72%	Rel Volume	0.60	Prev Close	1.04
Employees	194	LT Debt/Eq	5.77	Earnings	May 07 BMO	SMA200	-34.30%	Avg Volume	4.38M	Price	1.09
IPO	Mar 20, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-7.14% 3.63%	Trades		Volume	2,548,417	Change	4.81%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)